Oral Enteral Nutrition Tube Feeding on Stroke Survivors
Launched by AHMADU BELLO UNIVERSITY TEACHING HOSPITAL · Mar 4, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how a specific type of feeding, called Intermittent Oro-esophageal Tube Feeding, can help stroke survivors who have difficulty swallowing, known as dysphagia. The main focus is to see if this method of feeding can improve patients' mental health and their ability to interact socially. Participants will be divided into two groups: one will receive the new feeding method, while the other will receive a more traditional feeding method through a tube in the nose. The study will last for 15 days, and researchers will use surveys to measure any changes in social functioning, support, and mental health.
To participate in this trial, individuals must be at least 18 years old and have been diagnosed with a stroke, along with experiencing difficulties in swallowing. They should also be stable in their vital signs and not have severe cognitive issues. However, people with other serious health problems, such as certain neurological diseases or organ failures, will not be eligible. This trial is not yet recruiting participants, but it offers a chance to help researchers understand how different nutrition support methods can impact recovery after a stroke.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • age ≥ 18 years;
- • meeting the diagnostic criteria of stroke;
- • any degree of dysphagia at admission;
- • steady vital signs, without severe cognitive impairment or sensory aphasia.
- • transferred out within three weeks of hospitalization in the neurology department.
- Exclusion Criteria:
- • complicated with other neurological diseases;
- • damaged mucosa or incomplete structure in nasopharynx;
- • tracheostomy tube plugged;
- • unfeasible to the support of parenteral nutrition;
- • simultaneously suffering from liver, kidney failure, tumors, or hematological diseases.
About Ahmadu Bello University Teaching Hospital
Ahmadu Bello University Teaching Hospital (ABUTH) is a premier academic medical institution located in Zaria, Nigeria, dedicated to advancing healthcare through comprehensive clinical research and education. As a leading sponsor of clinical trials, ABUTH is committed to enhancing medical knowledge and improving patient outcomes by conducting rigorous, ethical research across various therapeutic areas. The institution leverages its extensive network of healthcare professionals and state-of-the-art facilities to facilitate innovative studies, ensuring adherence to the highest standards of clinical practice and regulatory compliance. Through collaboration with local and international partners, ABUTH aims to contribute significantly to the global understanding of health and disease.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Nieto Luis, Master
Study Director
Site Coordinator of United Medical Group
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported